Consensus pathways implicated in prognosis of colorectal cancer identified through systematic enrichment analysis of gene expression profiling studies

PLoS ONE

Volumn 6, Issue 4, 2011, Pages

  Lascorz, Jesús ^a   Chen, Bowang ^a   Hemminki, Kari ^a,b   Försti, Asta ^a,b  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b LUND UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

APOPTOSIS; ARTICLE; CELL PROLIFERATION; COLORECTAL CANCER; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE IDENTIFICATION; GENE MAPPING; OXIDATIVE PHOSPHORYLATION; PROGNOSIS; REPRODUCIBILITY; UPREGULATION; COLORECTAL TUMOR; GENETICS; HUMAN; META ANALYSIS (TOPIC); SIGNAL TRANSDUCTION; TUMOR GENE;

COLORECTAL NEOPLASMS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, NEOPLASM; HUMANS; META-ANALYSIS AS TOPIC; PROGNOSIS; SIGNAL TRANSDUCTION;

EID: 79955562970     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0018867     Document Type: Article

References (51)

1. Davies RJ, Miller R, Coleman N, (2005) Colorectal cancer screening: prospects for molecular stool analysis. Nat Rev Cancer 5: 199-209.
2. Nannini M, Pantaleo MA, Maleddu A, Astolfi A, Formica S, et al. (2009) Gene expression profiling in colorectal cancer using microarray technologies: results and perspectives. Cancer Treat Rev 35: 201-209.
3. Walther A, Johnstone E, Swanton C, Midgley R, Tomlinson I, et al. (2009) Genetic prognostic and predictive markers in colorectal cancer. Nat Rev Cancer 9: 489-499.
4. Cardoso J, Boer J, Morreau H, Fodde R, (2007) Expression and genomic profiling of colorectal cancer. Biochim Biophys Acta 1775: 103-137.
5. Sillars-Hardebol AH, Carvalho B, de Wit M, Postma C, Delis-van Diemen PM, et al. (2010) Identification of key genes for carcinogenic pathways associated with colorectal adenoma-to-carcinoma progression. Tumour Biol 31: 89-96.
6. Huang da W, Sherman BT, Lempicki RA, (2009) Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res 37: 1-13.
7. Rhee SY, Wood V, Dolinski K, Draghici S, (2008) Use and misuse of the gene ontology annotations. Nat Rev Genet 9: 509-515.
8. Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, et al. (2000) Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat Genet 25: 25-29.
9. Kanehisa M, Goto S, Kawashima S, Okuno Y, Hattori M, (2004) The KEGG resource for deciphering the genome. Nucleic Acids Res 32: D277-280.
10. Carmona-Saez P, Chagoyen M, Tirado F, Carazo JM, Pascual-Montano A, (2007) GENECODIS: a web-based tool for finding significant concurrent annotations in gene lists. Genome Biol 8: R3.
11. Zhang B, Kirov S, Snoddy J, (2005) WebGestalt: an integrated system for exploring gene sets in various biological contexts. Nucleic Acids Res 33: W741-748.
12. Chang JT, Nevins JR, (2006) GATHER: a systems approach to interpreting genomic signatures. Bioinformatics 22: 2926-2933.
13. Arango D, Laiho P, Kokko A, Alhopuro P, Sammalkorpi H, et al. (2005) Gene-expression profiling predicts recurrence in Dukes' C colorectal cancer. Gastroenterology 129: 874-884.
14. Bertucci F, Salas S, Eysteries S, Nasser V, Finetti P, et al. (2004) Gene expression profiling of colon cancer by DNA microarrays and correlation with histoclinical parameters. Oncogene 23: 1377-1391.
15. Fritzmann J, Morkel M, Besser D, Budczies J, Kosel F, et al. (2009) A colorectal cancer expression profile that includes transforming growth factor beta inhibitor BAMBI predicts metastatic potential. Gastroenterology 137: 165-175.
16. Jorissen RN, Gibbs P, Christie M, Prakash S, Lipton L, et al. (2009) Metastasis-Associated Gene Expression Changes Predict Poor Outcomes in Patients with Dukes Stage B and C Colorectal Cancer. Clin Cancer Res 15: 7642-7651.
17. Griffith OL, Melck A, Jones SJ, Wiseman SM, (2006) Meta-analysis and meta-review of thyroid cancer gene expression profiling studies identifies important diagnostic biomarkers. J Clin Oncol 24: 5043-5051.
18. Ioannidis JP, (2005) Microarrays and molecular research: noise discovery? Lancet 365: 454-455.
19. Chan SK, Griffith OL, Tai IT, Jones SJ, (2008) Meta-analysis of colorectal cancer gene expression profiling studies identifies consistently reported candidate biomarkers. Cancer Epidemiol Biomarkers Prev 17: 543-552.
20. Elbers CC, van Eijk KR, Franke L, Mulder F, van der Schouw YT, et al. (2009) Using genome-wide pathway analysis to unravel the etiology of complex diseases. Genet Epidemiol 33: 419-431.
21. Khatri P, Draghici S, (2005) Ontological analysis of gene expression data: current tools, limitations, and open problems. Bioinformatics 21: 3587-3595.
22. Warburg O, (1956) On respiratory impairment in cancer cells. Science 124: 269-270.
23. Cuezva JM, Sanchez-Arago M, Sala S, Blanco-Rivero A, Ortega AD, (2007) A message emerging from development: the repression of mitochondrial beta-F1-ATPase expression in cancer. J Bioenerg Biomembr 39: 259-265.
24. Ristow M, (2006) Oxidative metabolism in cancer growth. Curr Opin Clin Nutr Metab Care 9: 339-345.
25. Eng C, Kiuru M, Fernandez MJ, Aaltonen LA, (2003) A role for mitochondrial enzymes in inherited neoplasia and beyond. Nat Rev Cancer 3: 193-202.
26. de Moura MB, dos Santos LS, Van Houten B, (2010) Mitochondrial dysfunction in neurodegenerative diseases and cancer. Environ Mol Mutagen 51: 391-405.
27. Desgrosellier JS, Cheresh DA, (2010) Integrins in cancer: biological implications and therapeutic opportunities. Nat Rev Cancer 10: 9-22.
28. Barrier A, Boelle PY, Lemoine A, Tse C, Brault D, et al. (2005) Gene expression profiling of nonneoplastic mucosa may predict clinical outcome of colon cancer patients. Dis Colon Rectum 48: 2238-2248.
29. Barrier A, Boelle PY, Roser F, Gregg J, Tse C, et al. (2006) Stage II colon cancer prognosis prediction by tumor gene expression profiling. J Clin Oncol 24: 4685-4691.
30. Barrier A, Lemoine A, Boelle PY, Tse C, Brault D, et al. (2005) Colon cancer prognosis prediction by gene expression profiling. Oncogene 24: 6155-6164.
31. Barrier A, Roser F, Boelle PY, Franc B, Tse C, et al. (2007) Prognosis of stage II colon cancer by non-neoplastic mucosa gene expression profiling. Oncogene 26: 2642-2648.
32. Jiang Y, Casey G, Lavery IC, Zhang Y, Talantov D, et al. (2008) Development of a clinically feasible molecular assay to predict recurrence of stage II colon cancer. J Mol Diagn 10: 346-354.
33. Wang Y, Jatkoe T, Zhang Y, Mutch MG, Talantov D, et al. (2004) Gene expression profiles and molecular markers to predict recurrence of Dukes' B colon cancer. J Clin Oncol 22: 1564-1571.
34. Huang da W, Sherman BT, Lempicki RA, (2009) Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 4: 44-57.
35. Agrawal D, Chen T, Irby R, Quackenbush J, Chambers AF, et al. (2002) Osteopontin identified as lead marker of colon cancer progression, using pooled sample expression profiling. J Natl Cancer Inst 94: 513-521.
36. Bandres E, Malumbres R, Cubedo E, Honorato B, Zarate R, et al. (2007) A gene signature of 8 genes could identify the risk of recurrence and progression in Dukes' B colon cancer patients. Oncol Rep 17: 1089-1094.
37. Cavalieri D, Dolara P, Mini E, Luceri C, Castagnini C, et al. (2007) Analysis of gene expression profiles reveals novel correlations with the clinical course of colorectal cancer. Oncol Res 16: 535-548.
38. D'Arrigo A, Belluco C, Ambrosi A, Digito M, Esposito G, et al. (2005) Metastatic transcriptional pattern revealed by gene expression profiling in primary colorectal carcinoma. Int J Cancer 115: 256-262.
39. Eschrich S, Yang I, Bloom G, Kwong KY, Boulware D, et al. (2005) Molecular staging for survival prediction of colorectal cancer patients. J Clin Oncol 23: 3526-3535.
40. Garman KS, Acharya CR, Edelman E, Grade M, Gaedcke J, et al. (2008) A genomic approach to colon cancer risk stratification yields biologic insights into therapeutic opportunities. Proc Natl Acad Sci U S A 105: 19432-19437.
41. Grade M, Hormann P, Becker S, Hummon AB, Wangsa D, et al. (2007) Gene expression profiling reveals a massive, aneuploidy-dependent transcriptional deregulation and distinct differences between lymph node-negative and lymph node-positive colon carcinomas. Cancer Res 67: 41-56.
42. Ki DH, Jeung HC, Park CH, Kang SH, Lee GY, et al. (2007) Whole genome analysis for liver metastasis gene signatures in colorectal cancer. Int J Cancer 121: 2005-2012.
43. Kleivi K, Lind GE, Diep CB, Meling GI, Brandal LT, et al. (2007) Gene expression profiles of primary colorectal carcinomas, liver metastases, and carcinomatoses. Mol Cancer 6: 2.
44. Komuro K, Tada M, Tamoto E, Kawakami A, Matsunaga A, et al. (2005) Right- and left-sided colorectal cancers display distinct expression profiles and the anatomical stratification allows a high accuracy prediction of lymph node metastasis. J Surg Res 124: 216-224.
45. Kwon HC, Kim SH, Roh MS, Kim JS, Lee HS, et al. (2004) Gene expression profiling in lymph node-positive and lymph node-negative colorectal cancer. Dis Colon Rectum 47: 141-152.
46. Liersch T, Grade M, Gaedcke J, Varma S, Difilippantonio MJ, et al. (2009) Preoperative chemoradiotherapy in locally advanced rectal cancer: correlation of a gene expression-based response signature with recurrence. Cancer Genet Cytogenet 190: 57-65.
47. Lin YH, Friederichs J, Black MA, Mages J, Rosenberg R, et al. (2007) Multiple gene expression classifiers from different array platforms predict poor prognosis of colorectal cancer. Clin Cancer Res 13: 498-507.
48. Smith JJ, Deane NG, Wu F, Merchant NB, Zhang B, et al. (2010) Experimentally derived metastasis gene expression profile predicts recurrence and death in patients with colon cancer. Gastroenterology 138: 958-968.
49. Watanabe T, Kobunai T, Sakamoto E, Yamamoto Y, Konishi T, et al. (2009) Gene expression signature for recurrence in stage III colorectal cancers. Cancer 115: 283-292.
50. Watanabe T, Kobunai T, Tanaka T, Ishihara S, Matsuda K, et al. (2009) Gene expression signature and the prediction of lymph node metastasis in colorectal cancer by DNA microarray. Dis Colon Rectum 52: 1941-1948.
51. Yamasaki M, Takemasa I, Komori T, Watanabe S, Sekimoto M, et al. (2007) The gene expression profile represents the molecular nature of liver metastasis in colorectal cancer. Int J Oncol 30: 129-138.